The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Amylyx Pharmaceuticals, Inc.(NASDAQ:AMLX) 
Amylyx Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases in the United States and Canada. The company is developing AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taur...
Website: https://amylyx.com
Founded: 2013
IPO Price: $19 (Jan 07, 2022)
Sector: Healthcare
Industry: Biotechnology
Amylyx Pharmaceuticals . Number of Twitter Followers
Amylyx Pharmaceuticals . Days Payable Outstanding ttm (DPO)
Amylyx Pharmaceuticals . Days Receivable Outstanding ttm (DSO)
Amylyx Pharmaceuticals . Days Inventory Outstanding ttm (DIO)
Amylyx Pharmaceuticals . Op Cashflow Per Share ttm
Amylyx Pharmaceuticals . Free Cashflow Per Share ttm
Amylyx Pharmaceuticals . Cash Per Share ttm
Amylyx Pharmaceuticals . P/S ratio ttm
Amylyx Pharmaceuticals . (GAAP) P/E ratio ttm
Amylyx Pharmaceuticals . P/B ratio ttm
No extra charts and metrics for this ticker.